Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

No known treatment has showed significant long-term remission that is strong enough to declare a Lupus patient as cured. That was, until now.

Today, biotech experts at the French medical research company, Neovacs, are on the brink of a true landmark medical breakthrough. At Neovacs, the focus is not on drug treatment. Instead, Neovacs believes in the therapeutic philosophy of the body’s own immunity. (In other words, enhancing the immunity of the patient to develop an adequate response to fight disease.) It is currently in the advanced clinical trial stage of a therapeutic injectable vaccine for Lupus whose clinical trial results have been nothing short of astounding: Complete remission of symptoms for years, no side effects, no secondary treatments needed, and best of all, a remarkably strong immune system.

Watch The Balancing Act and see why experts are saying a cure for Lupus is, quite iterally, imminent.

On this new episode of The Balancing Act, we're talking golf tips and final expense insurance. Plus, another edition of Behind the Mystery. 

Final expense insurance is something we don't necessarily love to talk about. However, it's one of the most important plans to have. Learn more from Family First Life.

LPGA Pro Natalie Gulbis shares golf tips and more. Plus, TaylorMade makes a unique, all-in-one 11-piece set designed to help women play better golf.

Comments

comments